why choose us

First received: March 01, 2023

Clinical Trial: A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase 1, 2-Part, Multicenter, First-In-Human Dose-Escalation and Dose-Expansion Study of DS-1103a Combination Therapy in Subjects With Advanced Solid Tumors

Brief Summary: This study will evaluate the safety and efficacy of DS-1103a combination therapy in patients with advanced solid tumors.

Read more